The MUC1-C oncoprotein is aberrantly expressed in NSCLC and is associated with poor clinical outcomes [12, 13]; however, little was known about whether MUC1-C contributes to mutant KRAS signaling. Here, KRAS is linked to non-small cell lung carcinoma.